International workshop on omega-3 fatty acid and prevention of CHD

William Harris, Robert Katz

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

In May 2002, a meeting was held in Montreal, Canada, with the purpose of (1) arriving at a consensus on whether omega-3 LC-PUFA supplementation would reduce the risk of CHD death in a high-risk, primary prevention population, and (2) whether a primary prevention trial was needed and feasible to undertake. In the eventuality that the answers to both questions were affirmative, a second objective would be to focus on the essential elements of a protocol that would be scientifically valid, medically relevant, practical and fundable. Participants concluded that a high-risk, primary prevention trial was highly desirable in light of the rapidly growing evidence for cardioprotection in the secondary prevention setting and was feasible.

Original languageEnglish (US)
Pages (from-to)548-549
Number of pages2
JournalINFORM - International News on Fats, Oils and Related Materials
Volume15
Issue number8
StatePublished - Aug 2004
Externally publishedYes

Fingerprint

Omega-3 Fatty Acids
Primary Prevention
omega-3 fatty acids
Education
Secondary Prevention
Canada
death
Population

ASJC Scopus subject areas

  • Agricultural and Biological Sciences (miscellaneous)

Cite this

International workshop on omega-3 fatty acid and prevention of CHD. / Harris, William; Katz, Robert.

In: INFORM - International News on Fats, Oils and Related Materials, Vol. 15, No. 8, 08.2004, p. 548-549.

Research output: Contribution to journalArticle

@article{b3fd82f34a1b42c2a4d7febad946b3db,
title = "International workshop on omega-3 fatty acid and prevention of CHD",
abstract = "In May 2002, a meeting was held in Montreal, Canada, with the purpose of (1) arriving at a consensus on whether omega-3 LC-PUFA supplementation would reduce the risk of CHD death in a high-risk, primary prevention population, and (2) whether a primary prevention trial was needed and feasible to undertake. In the eventuality that the answers to both questions were affirmative, a second objective would be to focus on the essential elements of a protocol that would be scientifically valid, medically relevant, practical and fundable. Participants concluded that a high-risk, primary prevention trial was highly desirable in light of the rapidly growing evidence for cardioprotection in the secondary prevention setting and was feasible.",
author = "William Harris and Robert Katz",
year = "2004",
month = "8",
language = "English (US)",
volume = "15",
pages = "548--549",
journal = "INFORM - International News on Fats, Oils and Related Materials",
issn = "0897-8026",
publisher = "American Oil Chemists' Society",
number = "8",

}

TY - JOUR

T1 - International workshop on omega-3 fatty acid and prevention of CHD

AU - Harris, William

AU - Katz, Robert

PY - 2004/8

Y1 - 2004/8

N2 - In May 2002, a meeting was held in Montreal, Canada, with the purpose of (1) arriving at a consensus on whether omega-3 LC-PUFA supplementation would reduce the risk of CHD death in a high-risk, primary prevention population, and (2) whether a primary prevention trial was needed and feasible to undertake. In the eventuality that the answers to both questions were affirmative, a second objective would be to focus on the essential elements of a protocol that would be scientifically valid, medically relevant, practical and fundable. Participants concluded that a high-risk, primary prevention trial was highly desirable in light of the rapidly growing evidence for cardioprotection in the secondary prevention setting and was feasible.

AB - In May 2002, a meeting was held in Montreal, Canada, with the purpose of (1) arriving at a consensus on whether omega-3 LC-PUFA supplementation would reduce the risk of CHD death in a high-risk, primary prevention population, and (2) whether a primary prevention trial was needed and feasible to undertake. In the eventuality that the answers to both questions were affirmative, a second objective would be to focus on the essential elements of a protocol that would be scientifically valid, medically relevant, practical and fundable. Participants concluded that a high-risk, primary prevention trial was highly desirable in light of the rapidly growing evidence for cardioprotection in the secondary prevention setting and was feasible.

UR - http://www.scopus.com/inward/record.url?scp=4644228582&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=4644228582&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:4644228582

VL - 15

SP - 548

EP - 549

JO - INFORM - International News on Fats, Oils and Related Materials

JF - INFORM - International News on Fats, Oils and Related Materials

SN - 0897-8026

IS - 8

ER -